Navigation Links
DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
Date:5/17/2013

New York, New York (PRWEB) May 17, 2013

Bernstein Liebhard LLP, a nationwide law firm representing clients in DePuy Pinnacle hip implant lawsuits, notes that Johnson & Johnson has announced a decision to end sales of metal-on-metal hip replacements. According to a May 16th report from The New York Times, the phase-out will include the all-metal version of the Pinnacle hip replacement system, which utilizes the Ultamet liner.* Court records indicate that Johnson & Johnson is facing more than 4,000 DePuy Pinnacle hip lawsuits in a consolidated litigation underway in U.S. District Court, Northern District of Texas, all of which allege injuries due to the metal-on-metal hip replacement. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)

“In addition to the mounting number of DePuy Pinnacle hip implant lawsuits, Johnson & Johnson is also faced with the prospect that metal-on-metal hips will soon be subject to additional regulatory scrutiny. In light of those facts, the Company’s decision to end sales of the all-metal DePuy Pinnacle hip implant is not particularly surprising,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, serves on the Plaintiffs’ Steering Committee for the DePuy Pinnacle litigation. The Firm continues to offer free legal evaluations to individuals who suffered metallosis, early device failure, and other serious complications, allegedly due to the all-metal DePuy Pinnacle Hip Replacement System.

DePuy Pinnacle Hip Implant Lawsuits
According to the New York Times report, in announcing the metal-on-metal hip phase-out, Johnson & Johnson cited lower demand for such products, as well the recent action taken by the U.S. Food & Drug Administration (FDA) in regards to the devices. In January, the agency proposed an order that would make all-metal hips ineligible for 510(K) clearance, which allowed the products to come to market with no human testing. If the proposed rule is adopted, Johnson & Johnson and other metal-on-metal hip implant makers would be required to conduct human studies of their safety and efficacy in order to continue selling the devices.**

Court records indicate that the first trials in the federal DePuy Pinnacle hip replacement litigation will begin in September 2014. Plaintiffs in these claims allege the all-metal device is prone to wear and can shed dangerous amounts of metal debris, leading to premature implant failure, metallosis and other debilitating DePuy Pinnacle complications. The lawsuits further allege that the Pinnacle hip replacements suffer from the same design defects that prompted the 2010 DePuy ASR hip recall, and question whether they should have been recalled as well.

Alleged victims of DePuy Pinnacle complications may be entitled to compensation for their medical care, pain and suffering, and other damages. A wealth of information about DePuy Pinnacle hip implant lawsuits is available at Bernstein Liebhard’s website. For additional information, please call 800-511-5092today.

*nytimes.com/2013/05/17/business/jj-is-phasing-out-metal-replacement-hips.html?ref=health&_r=0
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuypinnacle-lawsuit.com/

Read the full story at http://www.prweb.com/releases/depuy-pinnacle-lawsuit/depuy-hip-replacement/prweb10745369.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuit Update: Rottenstein Law Group Comments on Delay of Second Federal Trial
2. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Rescheduling of First Bellwether Trial in Federal DePuy ASR Litigation
3. Alleged DePuy Knee Sleeve Failure Lawsuits Now Being Reviewed by Resource4thePeople Attorneys
4. DePuy ASR Lawsuit Update: Rottenstein Law Group Addresses J&J Motion to Appeal $8.3 Million Verdict
5. DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
6. California Jury Awards Man $8 Million after Injured by Defective DePuy ASR Hip Implant
7. DrugRisk Announces Launch of DePuy Hip Resource Center
8. Ongoing Litigation Over Failed DePuy and Stryker Hip Implants Continue Driving Traffic to Number One Website for Cobalt Chromium Toxicity Information
9. Compensation Justified in DePuy ASR $8.35 Million Verdict
10. Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
11. DePuy ASR Hip Replacement Lawsuit Lawyers at Wright & Schulte LLC Report Latest Developments in DePuy ASR Hip Implant Recall Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ... Success website has recently developed and published an informational resource that addresses frequently ... based on common inquiries the site’s team of third party administrator (TPA) contributors ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently ... balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... ... 27, 2017 , ... New patients who have sleep apnea in ... or without a referral. Sleep apnea is often left untreated because patients are not ... and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep apnea ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market Research, the ... 34 percent to $6.7 billion and can be expected to grow at ... five years, from $6.7 billion in 2016, to $22.6 billion in 2021. ... to purchase cannabis without a doctor,s recommendation. Voters in California ...
(Date:3/27/2017)... 2017 The staggering cost of cancer treatment ... access to the latest treatment options against cancer. Even ... patients have inadequate or no health insurance and are ... Access to modern cancer treatment is almost non-existent for ... The mission statements of pharmaceutical and biotech companies ...
Breaking Medicine Technology: